Intravenous Immunoglobulin Market – Synopsis
MRFR asserts that the global Intravenous Immunoglobulin market growing further will reach USD 8337.2 Million by 2023, registering ~5.9% CAGR during 2017 to 2023.
Intravenous Immunoglobulin (IVIg), a compound comprising of immune proteins (globulins) is administered into the bloodstream to treat patients with the inefficient or damaged immune systems. IVIg suffices the required antibodies by the human body to fight out the immune deficiency, and the consequent infectious attacks. Immunodeficiency Disorder could be a hereditary issue (Primary disorders), or caused due to the exposure to infections, mainly through bodily fluids, along with the cancer drugs and chemotherapy, aging is one of the key risk factor too that could put someone at greater risk of a damaged immune system.
Leveraging to the modern age, people have adopted the heady & unhealthy lifestyles which mirror the prevalence of damaged immune system. Factors such as immense of stress, lack of good quality sleep, inadequate & improper diet and sedentary lifestyle are fuelling the prevalence of Immunodeficiency Disorder. And, the augmented prevalence is predominantly driving the market growth.
Free sample report @ https://www.marketresearchfuture.com/sample_request/3137
The augmenting demand for alternate immunoglobulin replacement therapies, increasing R&D funding, rapidly developing healthcare infrastructure and increasing healthcare expenditures are major driving forces for the market growth. Technological advancements transpired in the medical science, are fostering the market growth exponentially, bringing up novel treatment procedures, & medications in the field of Intravenous Immunoglobulin (IVIg) Market.
Additionally, factors such as growing population and geriatric populace worldwide are fostering the Intravenous Immunoglobulin Market growth. Improving economic conditions are providing impetus to the market growth, enabling access to the quality life & to the improved healthcare. investments IVIg
Some of the fervent key players: including Baxter (US), Abeona Therapeutics (US), BDI Pharma (US), China Biologic Products, Inc. (China), Biotest AG. (Germany), Grifols Inc. (Spain), CSL Behring (US), Kedrion S.p.A (US), Octapharma (Switzerland), and Shire (Republic of Ireland) lead the global Intravenous Immunoglobulin market. Profiling them in its analysis MRFR finds out their strategies keeping them at the forefront of the market competition.
March 28, 2019 — CSL Behring (the US), a leading global biotherapeutics and biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products announced the receiving of an approval from Japan’s Ministry of Health, Labour and Welfare has for two of its immunoglobulin therapies – named Hizentra and Privigen for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy.
Global IVIg Market – Segments
For ease of understanding, the market is segmented into three key dynamics: –
By Types: IgA, (IgA1 & A2), IgD, IgE, IgG, and IgM.
By Applications : Chronic Inflammatory Demyelinating, Hypogammaglobulinemia Multifocal Motor Neuropathy, Immunodeficiency Diseases, CVID (common variable immunodeficiency), SCI (severe combined immunodeficiency), Primary Humoral Immunodeficiency, Unknown (idiopathic) Immunodeficiency diseases, Myasthenia Gravis, Guillain-Barre syndrome, MFS (Miller Fisher Syndrome), AMAN (Acute motor axonal neuropathy) and AMSAN (acute motor-sensory axonal neuropathy), Kawasaki disease, and ITP among others.
Industry, Innovation & Related News
Access Report Details @ https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137
Out of these, Hizentra which was previously approved for the treatment of primary immunodeficiency (PI) is now Japan’s first and only subcutaneous immunoglobulin (SCIG) treatment approved for maintenance therapy to treat CIDP. Privigen, an intravenous immunoglobulin (IVIG), is now approved for both acute and maintenance treatment of CIDP in Japan.
Intravenous Immunoglobulin Market – Geographical Analysis
Globally, North America is the leading Intravenous Immunoglobulin Market for IVIg, accounting for the largest revenue pocket, followed by the Europe & Asia Pacific markets, respectively. The US market backed by the high expenditure on healthcare is the largest contributor to the regional market growth. Moreover, increasing prevalence of immunodeficiency disorder and rising demand for treatment measures provide impetus to the market growth.
Asia Pacific Intravenous Immunoglobulin Market for the Intravenous Immunoglobulin is expected to perceive an exponential growth. Owing to the huge population and the burgeoning medical treatment market, India & China drive the regional market growth. Vietnam, Thailand, and Malaysia among the other South East Asian countries are projected to contribute significantly to the regional market growth. With the growing Medical Tourism markets in India & Malaysia the APAC region will register a significant CAGR during the review period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/intravenous-immunoglobulin-market-3137